|
⚲
|
| Chatham Cascade Fund III LLC | |
|---|---|
| Firm |
Chatham Capital Management LLC
✚
|
| Fund # | 805-1625896743 |
| CIK # | 0001465634 |
| Sale | 2009-07-17 ($300.0 M Offered, $20.9 M Sold) |
| Fund | Private Equity Fund |
| Phone | 7706182100 |
| Address | 400 Galleria Parkway, Ste 1950 Atlanta, 30339 |
| Source | [EDGAR] [IAPD] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | Chatham Credit Management III LLC |
| Custodian | Square 1 Bank, Imperial Capital LLC, Jefferies & Company Inc, PNC Bank NA |
| Auditor | KPMG LLP |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Nicholas Anacreonte | |
| Brian Reynolds | |
| Cheryl Boyd | |
| John Guy |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Cancer Targeting Systems, Inc.
✚
|
0.0 | |
|
ATeams, Inc.
✚
|
0.0 | |
|
ATS 218, a series of SAX Capital Series Fund III, LP
✚
|
0.0 | |
|
AU Fund I, a series of 5 Eyes Ventures, LP
✚
|
0.0 | |
|
AU Fund I, a series of Matt Bilotti AL Funds, LP
✚
|
0.0 | |
|
AU Fund I, a series of Ride Wave Ventures, LP
✚
|
0.0 | |
|
SAB IV Financial Industries Partnership L.P.
✚
|
0.0 | |
|
Diameter Credit (BDC) Access LP
✚
|
0.0 | |
|
Diamondback Acquisition, Inc.
✚
|
0.0 | |
|
Canamed, Inc.
✚
|
0.0 |